[HTML][HTML] Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter …
G Hou, B Liu, ZQ Fan, C Li, JP Zhang, YH Guo… - Frontiers in …, 2023 - frontiersin.org
Abstract Background: Alpha-fetoprotein (AFP) is a well-identified biomarker in hepatocellular
carcinoma (HCC). However, only limited AFP-related studies have evaluated its early …
carcinoma (HCC). However, only limited AFP-related studies have evaluated its early …
[HTML][HTML] Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter …
G Hou, B Liu, ZQ Fan, C Li, JP Zhang, YH Guo… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Background Alpha-fetoprotein (AFP) is a well-identified biomarker in hepatocellular
carcinoma (HCC). However, only limited AFP-related studies have evaluated its early …
carcinoma (HCC). However, only limited AFP-related studies have evaluated its early …
Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study …
G Hou, B Liu, ZQ Fan, C Li, JP Zhang… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Alpha-fetoprotein (AFP) is a well-identified biomarker in hepatocellular
carcinoma (HCC). However, only limited AFP-related studies have evaluated its early …
carcinoma (HCC). However, only limited AFP-related studies have evaluated its early …